MedElevator Войти в исследования
← Поиск публикаций

DOI 10.18632/oncotarget.15883

Медицинская библиотека · Oncotarget · 2017

An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness.

Rigolin Gian Matteo, Formigaro Luca, Cavallari Maurizio, Quaglia Francesca Maria, Lista Enrico, Urso Antonio, Guardalben Emanuele, Martinelli Sara, Saccenti Elena, Bassi Cristian, Lupini Laura, Bardi Maria Antonella, Volta Eleonora, Tammiso Elisa, Melandri Aurora, Negrini Massimo, Cavazzini Francesco, Cuneo Antonio

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

To evaluate the clinico-serological profile and to assess diagnostic parameters of myopathy in patients with systemic sclerosis (SSc)-associated myopathy.

METHODS

We explored the profiles of SSc-myopathy patients and matched non-myopathy SSc patients as well as different diagnostic measures for muscle affection. Additionally, the muscle performance of SSc-myopathy patients, assessed by the Manual Muscle Test for 8 muscle groups (MMT-8) and the Functional Index-2 (FI-2), was compared with that of patients with primary myositis.

RESULTS

In SSc-myopathy patients, the following features occurred significantly more often even after Bonferroni correction for multiple comparisons: immunosuppressive treatment (56.0% vs. 24.1%; p=0.0003), elevated levels of creatine kinase (CK) (48.3% vs. 5.3%, p<0.0001), anti-PM-Scl antibodies (30.4% vs. 4%, p=0.00048), and absence of RNA Polymerase III antibodies (7.3% vs. 28.3%, p<0.0001). The MMT-8 showed a mild muscle weakness in SSc-myopathy as well as in primary myositis patients with similar age and sex. Muscle endurance tested by the FI-2 was generally compromised in both cohorts, yet the distribution pattern of affected muscle groups differed between the two cohorts.

CONCLUSIONS

We confirmed previously described clinic-serological characteristics of SSc-myopathy patients. Our study suggests that autoantibody profile and CK levels may be helpful in establishing the diagnosis of SSc-myopathy. Whole-body MRI might be more accurate to capture the disease extent than MRI of selected muscle groups. Functional muscle tests validated for primary myositis did not perform well for the assessment of muscle function in patients with SSc-myopathy. Both, potential confounders such as skin, joint, and cardiovascular involvement as well as lack of sensitivity might have negatively affected the test performance in this population.

Для цитирования: Rigolin Gian Matteo, Formigaro Luca, Cavallari Maurizio, Quaglia Francesca Maria, Lista Enrico, Urso Antonio, Guardalben Emanuele, Martinelli Sara, Saccenti Elena, Bassi Cristian, Lupini Laura, Bardi Maria Antonella, Volta Eleonora, Tammiso Elisa, Melandri Aurora, Negrini Massimo, Cavazzini Francesco, Cuneo Antonio. An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness.. Oncotarget. 2017. DOI: 10.18632/oncotarget.15883.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.